日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of Aurora Kinase Induces Endogenous Retroelements to Induce a Type I/III IFN Response via RIG-I

抑制极光激酶可诱导内源性逆转录元件通过RIG-I诱导I/III型干扰素反应。

Choy, Lisa; Norris, Stephen; Wu, Xiumin; Kolumam, Ganesh; Firestone, Ari; Settleman, Jeffrey; Stokoe, David

Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity

EGFR突变型肺癌对酪氨酸激酶抑制剂治疗的获得性耐药促进PARP抑制剂的敏感性

Lynnette Marcar ,Kankana Bardhan ,Liliana Gheorghiu ,Patrick Dinkelborg ,Heike Pfäffle ,Qi Liu ,Meng Wang ,Zofia Piotrowska ,Lecia V Sequist ,Kerstin Borgmann ,Jeffrey E Settleman ,Jeffrey A Engelman ,Aaron N Hata ,Henning Willers

Challenges in validating candidate therapeutic targets in cancer

癌症候选治疗靶点验证面临的挑战

Settleman, Jeffrey; Sawyers, Charles L; Hunter, Tony

Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models

BCL-XL 和 MEK 抑制剂联合抑制的合成致死作用可促进 KRAS 突变癌症模型中的肿瘤消退

Corcoran, Ryan B; Cheng, Katherine A; Hata, Aaron N; Faber, Anthony C; Ebi, Hiromichi; Coffee, Erin M; Greninger, Patricia; Brown, Ronald D; Godfrey, Jason T; Cohoon, Travis J; Song, Youngchul; Lifshits, Eugene; Hung, Kenneth E; Shioda, Toshi; Dias-Santagata, Dora; Singh, Anurag; Settleman, Jeffrey; Benes, Cyril H; Mino-Kenudson, Mari; Wong, Kwok-Kin; Engelman, Jeffrey A

Lateral to End-on Conversion of Chromosome-Microtubule Attachment Requires Kinesins CENP-E and MCAK

染色体-微管连接的侧向到端向转换需要驱动蛋白CENP-E和MCAK

Bustos, Rodrigo I; Forget, Marie-Annick; Settleman, Jeffrey E; Hansen, Steen H; Kobayashi, Shunsuke; Schultz, Wolfram; Shrestha, Roshan L; Draviam, Viji M

Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells

靶向异常谷胱甘肽代谢以根除人类急性髓系白血病细胞

Pei, Shanshan; Minhajuddin, Mohammad; Callahan, Kevin P; Balys, Marlene; Ashton, John M; Neering, Sarah J; Lagadinou, Eleni D; Corbett, Cheryl; Ye, Haobin; Liesveld, Jane L; O'Dwyer, Kristen M; Li, Zheng; Shi, Lei; Greninger, Patricia; Settleman, Jeffrey; Benes, Cyril; Hagen, Fred K; Munger, Joshua; Crooks, Peter A; Becker, Michael W; Jordan, Craig T

A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer

厄洛替尼联合羟氯喹治疗晚期非小细胞肺癌的I期研究

Goldberg, Sarah B; Supko, Jeffrey G; Neal, Joel W; Muzikansky, Alona; Digumarthy, Subba; Fidias, Panos; Temel, Jennifer S; Heist, Rebecca S; Shaw, Alice T; McCarthy, Patricia O; Lynch, Thomas J; Sharma, Sreenath; Settleman, Jeffrey E; Sequist, Lecia V

EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling.

EGFR 配体在旁分泌和自分泌信号模型中表现出功能差异

Wilson Kristy J, Mill Christopher, Lambert Sydney, Buchman Jennifer, Wilson Timothy R, Hernandez-Gordillo Victor, Gallo Richard M, Ades Laura M C, Settleman Jeffrey, Riese David J 2nd

A chemical biology approach to developing STAT inhibitors: molecular strategies for accelerating clinical translation

利用化学生物学方法开发STAT抑制剂:加速临床转化的分子策略

Nelson, Erik A; Sharma, Sreenath V; Settleman, Jeffrey; Frank, David A

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

快速靶向分析人类肿瘤突变:指导个体化癌症治疗的临床平台

Dias-Santagata, Dora; Akhavanfard, Sara; David, Serena S; Vernovsky, Kathy; Kuhlmann, Georgiana; Boisvert, Susan L; Stubbs, Hannah; McDermott, Ultan; Settleman, Jeffrey; Kwak, Eunice L; Clark, Jeffrey W; Isakoff, Steven J; Sequist, Lecia V; Engelman, Jeffrey A; Lynch, Thomas J; Haber, Daniel A; Louis, David N; Ellisen, Leif W; Borger, Darrell R; Iafrate, A John